Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING HBV
Document Type and Number:
WIPO Patent Application WO/2021/228213
Kind Code:
A1
Abstract:
A combination comprising a tricycle compound and use thereof in the preparation of a medicament for treating HBV. The combination is a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof and any one drug in the following groups a-c: a. a hepatitis B surface antigen inhibitor, b. a reverse transcriptase inhibitor, and c. a hepatitis B surface antigen inhibitor and a reverse transcriptase inhibitor.

Inventors:
WU WENQIANG (CN)
ZHANG DONG (CN)
MA ZHIQIANG (CN)
ZHOU YIXIN (CN)
MAO JOHN (CN)
JIANG ZHIGAN (CN)
WANG JING (CN)
HE HAIYING (CN)
Application Number:
PCT/CN2021/093769
Publication Date:
November 18, 2021
Filing Date:
May 14, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/33; A61K31/55; A61K31/395; A61K31/40; A61K31/5365; A61P1/16; A61P31/20; C07D471/04; C07D487/00; C07D498/04
Domestic Patent References:
WO2018153285A12018-08-30
WO2018214875A12018-11-29
WO2018161960A12018-09-13
WO2020038456A12020-02-27
WO2018153285A12018-08-30
WO2018214875A12018-11-29
WO2018161960A12018-09-13
Foreign References:
CN102060786A2011-05-18
CN105102451A2015-11-25
CN106255684A2016-12-21
CN106459032A2017-02-22
CN202010412760A2020-05-15
CN202011633373A2020-12-31
Other References:
WANG HONG-LIANG; LIU XIA-LING; CAO SHUANG: "Anti-Hepatitis B Virus Drugs: Research Advances", JOURNAL OF INTERNATIONAL PHARMACEUTICAL RESEARCH, vol. 43, no. 1, 29 February 2016 (2016-02-29), CN , pages 134 - 138, XP009531790, DOI: 10.13220/j.cnki.jipr.2016.01.020
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: